Skip to main content

tavapadon

tavapadon: sourced relationships with 1 company · 1 clinical trial tracked.

tavapadon evidence translation

What we can confirm

What it means

Source-backed records connect tavapadon to CERE; that link alone does not prove the drug works.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

How could tavapadon → CERE affect its developer, and what evidence supports the link?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence2 indications · 1 study sponsors

Related indications

early- and late-stage Parkinson's diseaseParkinson Disease
Dated Pipeline Records (1)
CompanyDated record stage
Cerevel Therapeutics Holdings, Inc. (CERE)
developer · Reported 2022-03-01 · Current development: unknownSource
early- and late-stage Parkinson's disease
Phase 3
Clinical Trial Registry Records (1)

Expanded Access to Tavapadon

NCT07158827Registry updated 2026-02-10·N/A·ABBV
Available
Expanded AccessAbbVie

Frequently asked questions

Which companies have sourced relationships with tavapadon?

tavapadon has dated SEC/FDA relationship records for Cerevel Therapeutics Holdings, Inc..

How many clinical trials involve tavapadon?

BioSniper tracks 1 clinical trial involving tavapadon.